유방 영상 진단 시장 규모, 점유율, 동향, 예측 : 기술별, 최종사용자별, 지역별(2025-2033년)

The global breast imaging market size was valued at USD 4.86 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 9.30 Billion by 2033, exhibiting a CAGR of 7.10% from 2025-2033. North America currently dominates the market, holding a breast imaging market share of over 37.5% in 2024. The breast imaging market is driven by rising breast cancer prevalence, technological advancements in imaging modalities, and government initiatives promoting early detection. Increased awareness, expanding healthcare infrastructure, and artificial intelligence (AI)-driven diagnostics further boost market growth. Favorable reimbursement policies and growing demand for accurate, non-invasive screening solutions also contribute to industry expansion.

The rising incidence of breast cancer is a major driver in the breast imaging industry, necessitating early detection and advanced diagnostic solutions. In 2022, approximately 2.3 million women globally were diagnosed with breast cancer, resulting in about 670,000 deaths. However, the projections indicate a 38% increase in cases and a 68% rise in deaths by 2050. In the U.S., diagnoses have been growing by 1% annually, with a 1.4% increase per year among women under 50. This alarming trend has intensified awareness campaigns and government initiatives promoting frequent screenings, driving the adoption of mammography, ultrasound, and MRI technologies. Technological advancements like three-dimensional (3D) mammography and AI-powered imaging enhance accuracy, reducing false positives and unnecessary biopsies. Expanding healthcare infrastructure, particularly in emerging markets, improves access to screening centers, ensuring better patient outcomes and continuous innovation in imaging technology.

The U.S. breast imaging market is driven by high breast cancer prevalence, advanced healthcare infrastructure, and strong government initiatives promoting early detection with 88.90% market share. Widespread adoption of advanced imaging technologies, such as digital breast tomosynthesis (DBT) and AI-driven diagnostics, enhances accuracy and efficiency in screenings. Favorable reimbursement policies and increased awareness campaigns by organizations like the American Cancer Society further encourage regular mammograms. Additionally, ongoing research and development (R&D) efforts by key industry players contribute to technological advancements, improving imaging precision. The presence of major market players, coupled with rising investments in healthcare innovations, strengthening the breast imaging market growth. Expanding insurance coverage and growing demand for personalized diagnostics further support the increasing adoption of breast imaging solutions across the country.

Breast Imaging Market Trends:

Increasing Incidence of Breast Cancer

On of the primary breast imaging market trends is the increasing number of breast cancer cases is one of the leading factors driving the growth of the breast imaging sector. Early detection improves survival and hence the treatment, thus surging demand for advanced imaging. It is the most commonly diagnosed cancer among women, as per WHO, necessitating accurate and timely detection of breast cancer. According to the World Cancer Research Fund, it is anticipated that there will be around 2.1 million new breast cancer cases in 2030, strengthening the argument for effective screening and imaging solutions. The rise of breast cancer cases drives the introduction of advanced imaging technologies while pushing the health system and providers to adopt better options in secure diagnosis. The measure of early detection is instrumental in improving treatment outcomes, and the demand for breast imaging services rises to accommodate these increased demand variables and the market for breast imaging.

Technological Advancements in Imaging Techniques

Continuous advancement in breast imaging technology significantly influences enhancement in detection and management of breast illnesses and conditions and is projected as a key driver for market growth. Notably, advancement in digital mammography, 3D tomosynthesis, contrast-enhanced mammography, and AI-driven imaging solutions, all contribute to increased diagnostic precision and efficiency, which in turn drives adoption. Innovations such as these allow healthcare providers to make earlier and more precise diagnoses of breast cancer, leading to improved outcomes for patients. An excellent recent example is the MyBreastAI suite launched by GE HealthCare in November 2023; it combines three iCAD-introduced AI-driven applications: SecondLook for 2D mammography, ProFound AI for 3D mammography, and PowerLook Density Assessment. This suite uses AI technology to streamline breast imaging for quicker diagnosis, thereby improving access to this kind of imaging. These technologies are all answers to the growing demand for better and more accurate devices for cancer detection that will further facilitate the breast imaging market demand.

Government and Healthcare Initiatives for Breast Cancer Awareness

The increasing awareness campaigns and government initiatives are allowing more and more breast imaging services to be utilized as early detection is very crucial to survival. Governments and organizations around the world are introducing breast cancer screening programs, expanding access to imaging services, especially for underserved populations. These, in turn, have expanded diagnostics into areas where they had previously not been available, further spurring market growth. For instance, every two years, the government-sponsored national screening program of Australia, BreastScreen Australia, offers women ages 50-74 free mammograms to encourage screening and early detection. Moreover, Cancer Australia's September 2020 publication, "Guidance for the Management of Early Breast Cancer-Recommendations and Practice Points," emphasized the significance of early diagnosis, stimulating the development of advanced breast imaging technologies. These instances, accompanied by a growing awareness among the public, are playing an important role in increasing the demand for high-quality imaging solutions and expanding the breast imaging market globally.

Breast Imaging Industry Segmentation:

Analysis by Technology:

• Ionizing Breast Imaging
  • Mammography
  • Positron Emission Tomography-Computed Tomography
  • Molecular Breast Imaging
  • Positron Emission Mammography
  • Cone-Beam Computed Tomography
• Non-Ionizing Breast Imaging
  • Breast Ultrasound
  • Breast MRI
  • Automated Whole-Breast Ultrasound
  • Breast Thermography
  • Electric Impedance Tomography
  • Optical Imaging

According to the breast imaging market forecast, Ionizing breast imaging holds the majority share of 63.7% due to its widespread use in early breast cancer detection and diagnosis. Techniques such as mammography, digital breast tomosynthesis (DBT), and contrast-enhanced mammography provide high-resolution images, enabling accurate identification of abnormalities. The effectiveness of these methods in detecting microcalcifications and early-stage tumors makes them the preferred choice among healthcare providers. Additionally, government screening programs, rising breast cancer awareness, and increased adoption of advanced imaging technologies contribute to its dominance. The integration of artificial intelligence in mammography for improved diagnostic accuracy and workflow efficiency further strengthens market growth. Despite concerns over radiation exposure, continuous technological advancements in low-dose imaging ensure its continued preference in breast cancer diagnostics.

Analysis by End-User:

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Others

Based on the breast imaging market outlook, Hospitals hold the largest market share of 42.0% due to their comprehensive veterinary care services, advanced diagnostic capabilities, and specialized treatment options. These facilities offer a wide range of medical interventions, including surgeries, critical care, and disease management, making them the preferred choice for pet owners and livestock farmers. The presence of skilled veterinary professionals, access to high-end medical equipment, and increasing investments in hospital infrastructure contribute to their dominance. Additionally, rising pet adoption rates and growing awareness of preventive healthcare are driving demand for hospital-based veterinary services. Government initiatives and corporate investments in multi-specialty veterinary hospitals further strengthen their market position, ensuring better accessibility and higher standards of animal healthcare across urban and rural areas.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America holds the leading market position with a 37.5% breast imaging market share, fueled by a robust healthcare infrastructure, widespread adoption of advanced medical technologies, and rising healthcare expenditures. The region benefits from strong government initiatives supporting disease screening, early diagnosis, and treatment advancements. A growing prevalence of chronic diseases, coupled with a rising aging population, fuels demand for cutting-edge medical imaging and diagnostic solutions. Additionally, robust research and development activities, along with a high concentration of key industry players, contribute to market growth. Favorable reimbursement policies and widespread health insurance coverage further boost accessibility to medical imaging services. Increasing awareness programs and strong regulatory frameworks ensure continued investment in healthcare innovations, reinforcing North America's market dominance.

Key Regional Takeaways:

United States Breast Imaging Market Analysis

Growing demand for next-generation breast imaging technologies in the US stems from the large number of regulatory clearances, growing rates of breast cancer diagnoses, and revised screening guidelines. In January 2021, Seno Medical Instruments gained Premarket Approval from CDRH for its new diagnostic modality in imaging, which is centered on the malignant vs. benign differentiation of breast lesions. This approval supports the rising adoption of advanced imaging solutions for accurate diagnosis. Meanwhile, the guidance from the CDC, released in September 2020, and recommendations from major institutes for cancer research on yearly screenings for women, aged 40 to 49, run a further push for the demand for imaging services. The Breastcancer.org states that around 281,550 fresh cases of invasive in women were diagnosed in the U.S. of breast cancer, enhancing the demand for early detection technologies. A combination of these factors results in the expanding breast imaging market in the United States.

Europe Breast Imaging Market Analysis

The increase in aging populace in Europe is a key driving force behind the growth of the breast imaging market, as aging is a significant risk factor for breast cancer. As per a report by the European Union, by February 2025, over 21.3% of the total EU population which is approximately 448.8 million-was aged 65 years and older in 2023. The changing demographics are foreseen to result in an increased incidence of breast cancer, hence driving the demand for advanced breast imaging technologies. With focus across Europe on early detection and preventive care, investments in screening programs and diagnostic imaging solutions are continuing to rise. Governments and healthcare companies are expanding the access to mammography, ultrasound, and MRI-based breast imaging services to respond to the rising need for timely and accurate diagnoses. Thus, the rising population and growing healthcare initiatives were expected to drive the European breast imaging market in the coming years.

Asia Pacific Breast Imaging Market Analysis

The increasing number of breast cancer incidences recorded in the Asia Pacific region, coupled with improving healthcare infrastructure, act as the main growth driver for the breast imaging market. According to a report published by Breast Cancer Network Australia in September 2024, approximately 20,973 women and 221 men will be diagnosed with breast cancer in Australia alone. This rising number of cases highlights the requirement for advanced breast imaging technologies to enable early identification and efficient treatment.

Governments and healthcare organizations in the region are investing in newer screening technologies, including digital mammography, ultrasound, and MRI services. Supportive initiatives on breast cancer awareness and early screening programs provide good access to breast imaging services, especially in developing countries. With ongoing improvements in healthcare infrastructure and adoption of state-of-the-art imaging technologies, the demand for breast imaging solutions in the Asia Pacific region is projected to grow steadily in the future.

Latin America Breast Imaging Market Analysis

Breast cancer is the most prevalent form of cancer among women in Latin America and Caribbean countries, compelling a growing interest in the development of advanced breast imaging technologies. According to the American Society of Clinical Oncology (ASCO), more than 200,000 new cases of breast cancer were diagnosed in the region in 2020. As such increased incidence demands for greater awareness and provides an impelling reason for the development of breast imaging market.

Breast cancer screening programs are actively implemented across the Latin American region by the government and health agencies to promote the early detection of this disease. Investment in advanced imaging modalities, including digital mammography, ultrasound, and MRI, has opened the door to equitable access to high-quality diagnostics. Also, awareness campaigns and partnerships with global health institutions are slowly closing the programs that detect breast cancer among poor communities. As these health systems develop and screening access improves, demand for breast imaging solutions is expected to rise steadily across Latin America.

Middle East and Africa Breast Imaging Market Analysis

The trials of rising breast cancer incidence in the Middle East and North Africa (MENA) are among the major forces influencing breast imaging growth. In 2019, there were 835,576 breast cancer cases among females and 10,938 among males, as per the Institute for Health Metrics and Evaluation (IHME). Incidence and burden of breast cancer here drive home the point quite well about the need for deployment of advanced imaging technology and methods for early detection and improved outcomes.

Governments and healthcare institutions in the Middle East and Africa are investing in expanding access to breast cancer screening programs. Countries such as the UAE, Saudi Arabia, and South Africa are implementing nationwide initiatives promoting regular mammograms and early diagnosis. The increasing adoption of digital mammography, 3D tomosynthesis, and AI-powered imaging solutions increases accuracy and accessibility to diagnosis. Furthermore, rising healthcare awareness, improved medical infrastructure, and partnerships with international health organizations will calm beyond the horizon in the regional market.

Competitive Landscape:

The breast imaging market is highly competitive, driven by continuous technological advancements and innovation in diagnostic imaging solutions. Market players focus on research and development to enhance imaging accuracy, reduce false positives, and integrate artificial intelligence for improved diagnostics. The industry sees strong competition in product differentiation, with companies offering advanced modalities such as digital breast tomosynthesis, automated breast ultrasound, and molecular breast imaging. Strategic collaborations with healthcare providers and research institutions play a crucial role in market positioning. Regulatory approvals and compliance with stringent safety standards influence market dynamics. Additionally, increasing mergers and acquisitions help companies expand their portfolios and global reach, intensifying competition while driving the overall evolution of breast imaging technologies.

The report provides a comprehensive analysis of the competitive landscape in the breast imaging market with detailed profiles of all major companies, including:

• Allengers Medical Systems Limited
• Aurora Health Care Inc. (Schoen Clinic)
• Canon Inc.
• Carestream Health Inc. (Onex Corporation)
• Delphinus Medical Technologies
• Dilon Technologies Inc.
• Fujifilm Holdings Corporation
• GE Healthcare
• Hologic Inc.
• Koninklijke Philips N.V.
• Micrima Limited
• Planmed Oy
• Siemens Healthineers AG (Cerner Corporation)
• Toshiba Corporation

Key Questions Answered in This Report

• 1.How big is the breast imaging market?
• 2.What is the future outlook of breast imaging market?
• 3.What are the key factors driving the breast imaging market?
• 4.Which region accounts for the largest breast imaging market share?
• 5.Which are the leading companies in the global breast imaging market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Breast Imaging Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Technology

• 6.1 Ionizing Breast Imaging
  • 6.1.1 Market Trends
  • 6.1.2 Major Types
    • 6.1.2.1 Mammography
    • 6.1.2.2 Positron Emission Tomography-Computed Tomography
    • 6.1.2.3 Molecular Breast Imaging
    • 6.1.2.4 Positron Emission Mammography
    • 6.1.2.5 Cone-Beam Computed Tomography
  • 6.1.3 Market Forecast
• 6.2 Non-Ionizing Breast Imaging
  • 6.2.1 Market Trends
  • 6.2.2 Major Types
    • 6.2.2.1 Breast Ultrasound
    • 6.2.2.2 Breast MRI
    • 6.2.2.3 Automated Whole-Breast Ultrasound
    • 6.2.2.4 Breast Thermography
    • 6.2.2.5 Electric Impedance Tomography
    • 6.2.2.6 Optical Imaging
  • 6.2.3 Market Forecast

7 Market Breakup by End-User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Diagnostic Imaging Centers
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Ambulatory Surgical Centers
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Indicators

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Allengers Medical Systems Limited
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Aurora Health Care Inc. (Schoen Clinic)
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Canon Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Carestream Health Inc. (Onex Corporation)
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 SWOT Analysis
  • 13.3.5 Delphinus Medical Technologies
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 Dilon Technologies Inc.
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
  • 13.3.7 Fujifilm Holdings Corporation
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 GE Healthcare
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis
  • 13.3.9 Hologic Inc.
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis
  • 13.3.10 Koninklijke Philips N.V.
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
    • 13.3.10.4 SWOT Analysis
  • 13.3.11 Micrima Limited
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 Financials
  • 13.3.12 Planmed Oy
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio
    • 13.3.12.3 Financials
  • 13.3.13 Siemens Healthineers AG (Cerner Corporation)
    • 13.3.13.1 Company Overview
    • 13.3.13.2 Product Portfolio
    • 13.3.13.3 Financials
  • 13.3.14 Toshiba Corporation
    • 13.3.14.1 Company Overview
    • 13.3.14.2 Product Portfolio
    • 13.3.14.3 Financials
    • 13.3.14.4 SWOT Analysis